Interviews on VVM history
Ümit Kartoğlu talked to John Lloyd, Michel Zaffran, Peter Evans, Julie Milstien and Dario Cresci on VVM history. Lloyd, Zaffran, Evans and Milstien worked together in WHO HQ on VVM during its early development stages as well as its implementation. Cresci was on the other side of the table - the industry. In 2001, Kartoğlu joined the team, but after the departure of Lloyd and Evans from WHO.
The following interviews bring interesting stories to daylight. When Kartoğlu asked what was next, Lloyd, Zaffran, Evans, Milstien and Cresci all stressed the same point: using VVM to allow immunization programmes to exploit the stability of each vaccine. To use it to the greatest possible extent to minimizing distribution costs, and increasing flexibility in the handling of vaccines in the field, thus helping to make operations more effective. They all agreed that the mission is now reducing the dependency on the cold chain. VVM is seen as the answer to this challenge.